» Articles » PMID: 39567833

Melanin-like Nanoparticles As a Potential Novel Therapeutic Approach in ADPKD

Overview
Journal EMBO Mol Med
Specialty Molecular Biology
Date 2024 Nov 20
PMID 39567833
Authors
Affiliations
Soon will be listed here.
References
1.
Hansen J, Kaiser F, Leyendecker P, Stuven B, Krause J, Derakhshandeh F . A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation. EMBO Rep. 2022; 23(8):e54315. PMC: 9346484. DOI: 10.15252/embr.202154315. View

2.
Padovano V, Podrini C, Boletta A, Caplan M . Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat Rev Nephrol. 2018; 14(11):678-687. DOI: 10.1038/s41581-018-0051-1. View

3.
Zhou X, Torres V . Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling. Front Mol Biosci. 2022; 9:981963. PMC: 9478168. DOI: 10.3389/fmolb.2022.981963. View

4.
Cassina L, Chiaravalli M, Boletta A . Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression. FASEB J. 2020; 34(5):6493-6507. DOI: 10.1096/fj.201901739RR. View

5.
Sun Y, Zou Q, Yu H, Yi X, Dou X, Yang Y . Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB. EMBO Mol Med. 2024; 17(1):169-192. PMC: 11730739. DOI: 10.1038/s44321-024-00167-2. View